Participants’ blood samples were drawn years before their dementia diagnosis.
Sudha Seshadri, M.D., founding director of the Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases at UT Health San Antonio, is co-leader and senior author on research announced March 6 that identifies novel biomarkers of risk for future dementia.
Dementia is a rising tidal wave of devastation for families and society. Age is the biggest risk factor. Alzheimer’s disease, which is the leading cause of dementia, is the sixth-leading cause of death in the United States, and more than 5 million Americans are currently living with Alzheimer’s. That figure is expected to triple by 2050.
The discovery is described in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. The study analyzed small molecules called metabolites in blood samples drawn from 22,623 individuals, including 995 who went on to develop dementia. The p
articipants were enrolled in eight research cohorts in five countries.
Associations with lower, higher risk
Researchers found that higher blood concentrations of molecules called branched-chain amino acids were associated with lower risk of future dementia. Another molecule, creatinine, and two very low-density lipoprotein (VLDL)-specific lipoprotein lipid subclasses also were associated with lower risk of dementia.
One high-density lipoprotein (HDL) and one VLDL lipoprotein subclass were associated with increased dementia risk.
These findings will broaden the search for drug targets in dementia caused by Alzheimer’s disease, vascular disease and other subtypes, said Dr. Seshadri, professor of neurology at UT Health San Antonio. Formerly of Boston University, Dr. Seshadri is a senior investigator in the long-running Framingham Heart Study and leads the neurology working group within several international consortia.
“It is now recognized that we need to look beyond the traditionally studied amyloid and tau pathways and understand the entire spectrum of pathology involved in persons who present with symptoms of Alzheimer’s disease and other dementias,” Dr. Seshadri said. “It is exciting to find new biomarkers that can help us identify persons who are at the highest risk of dementia.”
In the future, the Glenn Biggs Institute may investigate the feasibility of developing a diagnostic exam, such as a blood test, to assess each patient’s molecular signature of dementia risk. The signature could include blood concentration of branched-chain amino acids. The altered metabolite signatures were observed years before the diagnosis of dementia when those study participants were healthy, Dr. Seshadri said. If a test were to become available, therapy could be initiated earlier.
The study was in persons of European ancestry and was carried out in collaboration with researchers in Finland, the Netherlands, the United Kingdom and Estonia. Dr. Seshadri is eager to replicate it in South Texas. “The Glenn Biggs Institute at UT Health San Antonio will expand these studies to include the diverse racial and ethnic groups who live in South Texas,” she said.
Branched-chain amino acids are nutrients that the body obtains from proteins in foods such as meat and legumes. These amino acids include leucine, isoleucine and valine. “Valine has previously been shown to be involved in determining the risk of diabetes, which is a particularly big problem in our region, especially among the region’s large Hispanic population,” Dr. Seshadri said. “Now it is shown to be associated with the risk of Alzheimer’s dementia. We want to investigate for any connections.”
Metabolites are influenced by genetic and environmental factors, and their levels can be modified through dietary and pharmacological interventions. “I hope that people reading about this study will understand that they can take ownership of their health,” Dr. Seshadri said. “The lifestyle decisions they make, such as adopting a Mediterranean or other healthful diet, can affect these metabolites in ways we do not fully understand.”
Further studies can clarify whether the branched-chain amino acids and other molecules play a causal role in the dementia disease process or are merely early markers of the disease, Dr. Seshadri said.
The Latest on: Dementia risk
Having 5 or more babies may increase Alzheimer's risk by 70 percent, study finds
on July 18, 2018 at 5:16 pm
However, men carrying ApoE-4 have just a slightly elevated risk. What is it about women that might increase their odds of developing dementia? An obvious target for research has been hormones and the ... […]
Mind Your Risk: New campaign highlights high blood pressure and dementia
on July 18, 2018 at 4:06 pm
The National Institutes of Health have launched a new campaign called Mind Your Risks. The campaign is meant to help the millions of people who have uncontrolled high blood pressure better understand ... […]
Giving birth to more children raises risk of Alzheimer’s, study suggests
on July 18, 2018 at 3:00 pm
Dr Doug Brown, Chief Policy and Research Officer at Alzheimer's Society, said: "We know women are more at risk of developing dementia than men but we don't yet know why - and as it's the only one of t... […]
Being a Mother to Five or More Children Linked to Alzheimer's Risk in Study
on July 18, 2018 at 1:00 pm
He stressed: “This research shouldn’t give women who’ve given birth several times any cause for concern; it does highlight interesting links between changing hormone levels and dementia risk, but ther... […]
Apathy Tied to Higher Dementia Risk in Memory Clinic Patients
on July 18, 2018 at 8:32 am
Apathy was tied to a heightened risk for incident dementia in older adults. Note that a subgroup analysis showed this relationship slightly weakened among older adults with cognitive impairment. Apath... […]
Older adults with apathy may be at higher risk for dementia
on July 18, 2018 at 8:18 am
Among older adult patients in memory clinics, apathy was linked with an almost doubled risk for incident dementia, according to findings published in JAMA Psychiatry. “Apathy has been associated with ... […]
Sleep disturbances linked to increased dementia risk
on July 18, 2018 at 4:04 am
Researchers at Karolinska Institutet in Sweden report that sleep disturbances in midlife or in late life are associated with a higher risk for developing dementia in old age. The results are published ... […]
What is vascular dementia and how can you reduce the risk of developing it?
on July 17, 2018 at 5:05 am
You may not have heard of it, but vascular dementia affects around 150,000 people in the UK every year. Vascular dementia is the second most common type of dementia, after Alzheimer’s disease, and it ... […]
Surprising factors can significantly reduce Dementia risk
on July 16, 2018 at 10:32 am
WEBVTT GOOD NEWS THOUGH. I LOVE COFFEE. BEING SOCIAL, EXERCISING, AND GRADUATING FROM HIGH SCHOOL ARE ALL FACTORS THAT CAN SIGNIFICANTLY REDUCE THE RISK OF DEMENTIA. I TALKED TO A LOCAL DOCTOR TRYING ... […]
Herpes – A Risk for Alzheimer's Disease
on July 16, 2018 at 6:40 am
Herpes simplex virus type-1 leads to an increased risk of developing Alzheimer's disease. Aggressive antiviral drugs for herpes treatment may reduce dementia risk. Alzheimer's disease may be associate... […]
via Google News and Bing News